NASDAQ:MGLN - Magellan Health Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $95.00
  • Forecasted Upside: 0.27 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$94.74
▲ +0.07 (0.07%)

This chart shows the closing price for MGLN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Magellan Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MGLN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MGLN

Analyst Price Target is $95.00
▲ +0.27% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Magellan Health in the last 3 months. The average price target is $95.00, with a high forecast of $95.00 and a low forecast of $95.00. The average price target represents a 0.27% upside from the last price of $94.74.

This chart shows the closing price for MGLN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 2 investment analysts is to hold stock in Magellan Health. This rating has held steady since January 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/19/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/15/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$92.00 ➝ $95.00Low
1/6/2021StephensDowngradeOverweight ➝ Equal Weight$95.00N/A
11/13/2020StephensUpgradeEqual Weight ➝ Overweight$83.00 ➝ $98.00High
9/10/2020Bank of AmericaBoost Price TargetBuy$86.00 ➝ $90.00Low
7/30/2020Jefferies Financial GroupBoost Price TargetBuy$85.00 ➝ $96.00Medium
11/11/2019StephensReiterated RatingEqual Weight$65.00 ➝ $67.00Low
2/22/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$84.00High
1/14/2019StephensInitiated CoverageEqual ➝ Equal Weight$68.00High
11/13/2018SVB LeerinkDowngradeOutperform ➝ Market Perform$90.00 ➝ $70.00High
11/12/2018Raymond JamesLower Price TargetOutperform ➝ Buy$85.00 ➝ $72.00Low
7/30/2018Raymond JamesLower Price TargetOutperform ➝ Buy$105.00 ➝ $85.00Low
5/1/2018Raymond JamesUpgradeMarket Perform ➝ OutperformMedium
3/15/2018SVB LeerinkUpgradeMarket Perform ➝ OutperformMedium
12/2/2017Raymond JamesReiterated RatingHoldHigh
12/1/2017KeyCorpSet Price TargetBuy$105.00High
10/13/2017Jefferies Financial GroupReiterated RatingBuy$94.00N/A
9/22/2017KeyCorpReiterated RatingBuy$89.00Low
7/13/2017KeyCorpUpgradeSector Weight ➝ Overweight$91.00High
6/25/2017SVB LeerinkReiterated RatingOutperform$68.00 ➝ $73.00Low
2/24/2017Jefferies Financial GroupLower Price TargetBuy$89.00 ➝ $88.00N/A
12/23/2016Jefferies Financial GroupReiterated RatingBuy$89.00N/A
11/28/2016SVB LeerinkReiterated RatingMarket Perform$60.00 ➝ $78.00N/A
11/23/2016BarclaysBoost Price TargetUnderweight$61.00 ➝ $69.00N/A
11/18/2016Jefferies Financial GroupReiterated RatingBuy$78.00N/A
(Data available from 10/20/2016 forward)

News Sentiment Rating

0.83 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/22/2021
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/21/2021
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
9/20/2021
  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/20/2021

Current Sentiment

  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Magellan Health logo
Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment includes the Behavioral & Specialty Health reporting unit, which provides carve-out management services for behavioral health, employee assistance plans, and other areas of specialty healthcare. The Pharmacy Management segment comprises of services that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.
Read More

Today's Range

Now: $94.74
Low: $94.60
High: $94.75

50 Day Range

MA: $94.64
Low: $94.55
High: $94.78

52 Week Range

Now: $94.74
Low: $70.95
High: $95.43

Volume

60,257 shs

Average Volume

265,554 shs

Market Capitalization

$2.49 billion

P/E Ratio

7.96

Dividend Yield

N/A

Beta

1.19

Frequently Asked Questions

What sell-side analysts currently cover shares of Magellan Health?

The following sell-side analysts have issued stock ratings on Magellan Health in the last year: Jefferies Financial Group Inc., Stephens, and Zacks Investment Research.
View the latest analyst ratings for MGLN.

What is the current price target for Magellan Health?

2 Wall Street analysts have set twelve-month price targets for Magellan Health in the last year. Their average twelve-month price target is $95.00, suggesting a possible upside of 0.3%. Stephens has the highest price target set, predicting MGLN will reach $95.00 in the next twelve months. Stephens has the lowest price target set, forecasting a price of $95.00 for Magellan Health in the next year.
View the latest price targets for MGLN.

What is the current consensus analyst rating for Magellan Health?

Magellan Health currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MGLN, but not buy more shares or sell existing shares.
View the latest ratings for MGLN.

What other companies compete with Magellan Health?

Other companies that are similar to Magellan Health include UnitedHealth Group, Anthem, Cigna, Humana, Centene, Molina Healthcare and Triple-S Management.

How do I contact Magellan Health's investor relations team?

Magellan Health's physical mailing address is 4801 E. Washington Street, Phoenix AZ, 85034. The company's listed phone number is (800) 642-1716 and its investor relations email address is [email protected] The official website for Magellan Health is www.magellanhealth.com.